1. Abildgaard, U., Lindahl, A. K., Sandset, P. M., 1991, Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood, Haemostas., in press.
2. Broze, G. J., Warren, L. A., Novotny W.F., Higuchi D. A., Girard T.J., 1988, Miletich J.P., The lipoprotein — associated coagulation inhibitor that inhibits the factor VII tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action, Blood, 71:335–343.
3. Hinz, U., Klaus, J. G-H., Müller-Berghaus, P., Müller-Berghaus, G., 1991, Mechanism of extrinsic pathway inhibitor stimulation by heparin in umbilical vein endothelial cells, Thromb Haemost., 65:952.
4. Jacobsen, P. B., Lindahl, A. K., Norrheim, L., Nordfang, O., Sandset, P. M., Abildgaard, U., 1990, Separation of plasma by heparin sepharose chromatography, Fibrinolysis. 4(suppl.1): 24.
5. Lindahl, A. K., Sandset, P. M., Abildgaard, U., Andersson, T. R., Harbitz, T. B., 1989, Increased levels of extrinsic pathway inhibitor and decreased levels of other coagulation inhibitors in advanced cancer, Acta Chir Scand., 155: 389–393.